Islam, Shahriar
Inglese, Marianna
Grech-Sollars, Matthew
Aravind, Preetha
Dubash, Suraiya
Barwick, Tara D.
O’Neill, Kevin
Wang, James
Saleem, Azeem
O’Callaghan, James
Anchini, Giulio
Williams, Matthew
Waldman, Adam
Aboagye, Eric O.
Funding for this research was provided by:
Medical Research Council (MR/N020782/1)
NIHR Imperial Biomedical Research Centre (WSCC_P62585)
Article History
Received: 20 March 2023
Accepted: 4 July 2023
First Online: 25 July 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was granted by Yorkshire & The Humber – South Yorkshire Research Ethics Committee (REC#:18/YH/0082; IRAS ID:228245). The administration of Radioactivity was approved by the Administration of Radioactive Substances Advisory Committee, UK.
: Written informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of images in all figures.
: Financial interests: Eric O. Aboagye is inventor on a patent involving FPIA and has served in an advisor capacity to Radiopharm Theranostics Ltd and AstraZeneca. The authors declare no other relevant competing interests.